Ceapro Inc
XTSX:CZO
Ceapro Inc
Research & Development
Ceapro Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ceapro Inc
XTSX:CZO
|
Research & Development
-CA$2.8m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-14%
|
|
|
EcoSynthetix Inc
TSX:ECO
|
Research & Development
-$1.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
11%
|
|
|
5N Plus Inc
TSX:VNP
|
Research & Development
-$4.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nano One Materials Corp
TSX:NANO
|
Research & Development
-CA$3.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-31%
|
|
|
Neo Performance Materials Inc
TSX:NEO
|
Research & Development
-$18.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Ceapro Inc
Glance View
Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. The company is headquartered in Edmonton, Alberta. The firm's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The firm operates through two segments: the active ingredient product technology industry and the cosmeceutical industry. The firm is engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The company supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. Its pipeline Oat Beta Glucan and Avenanthramides. The Company’s wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc., Ceapro USA Inc., and JuventeDC Inc.
See Also
What is Ceapro Inc's Research & Development?
Research & Development
-2.8m
CAD
Based on the financial report for Dec 31, 2023, Ceapro Inc's Research & Development amounts to -2.8m CAD.
What is Ceapro Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-14%
Over the last year, the Research & Development growth was -54%. The average annual Research & Development growth rates for Ceapro Inc have been -20% over the past three years , -4% over the past five years , and -14% over the past ten years .
